NCT03375606View on ClinicalTrials.gov

Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults

PHASE1TerminatedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

June 22, 2020

Study Completion Date

June 22, 2020

Conditions

Healthy

Interventions

BIOLOGICAL

CSL730

Solution for IV infusion

OTHER

Placebo

Saline solution for IV infusion

Trial Locations (2)

Unknown

PRA Health Sciences, Groningen

Hammersmith Medicines Research, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CSL Behring

INDUSTRY